Jaunpur leads by distributing loans beyond the target under the 'Mukhyamantri Yuva Udyami Vikas Abhiyan'

Lucknow, April 2 -- Chief Minister Yogi Adityanath is continuously taking necessary steps to move the state towards becoming a one-trillion-dollar economy. As part of this effort, several schemes are ... Read More

Singapore Clinical Trial: ROSETTA HCC-206: An Open-Label, Multi-Center, Randomized Phase 1/2 Study of Pumitamig Alone or In Combination with Ipilimumab in Participants with First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC)

Singapore, April 2 -- The Health Sciences Authority received information related to the study titled 'ROSETTA HCC-206: An Open-Label, Multi-Center, Randomized Phase 1/2 Study of Pumitamig Alone or In ... Read More

Singapore Clinical Trial: Phase II Open-label Study Evaluating Ivonescimab in PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma

Singapore, April 2 -- The Health Sciences Authority received information related to the study titled 'Phase II Open-label Study Evaluating Ivonescimab in PD-1 Resistant Recurrent or Metastatic Nasopha... Read More

Singapore Clinical Trial: A Phase 2 Multi-center, Randomized, Open-label Study to Assess the Efficacy and Safety of AHB-137 in Nucleos(t)ide Analogue-treated Participants with HBeAg Negative Chronic Hepatitis B in the Asia Pacific Region

Singapore, April 2 -- The Health Sciences Authority received information related to the study titled 'A Phase 2 Multi-center, Randomized, Open-label Study to Assess the Efficacy and Safety of AHB-137 ... Read More

Singapore Clinical Trial: Evaluating the Clinical and Economic Outcomes of Adding Semaglutide to Standard of Care in Adult Patients with Poorly Controlled Type 2 Diabetes

Singapore, April 2 -- The Health Sciences Authority received information related to the study titled 'Evaluating the Clinical and Economic Outcomes of Adding Semaglutide to Standard of Care in Adult P... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Revumenib in Combination with Intensive Chemotherapy in Participants with Newly Diagnosed AML with an NPM1 mutation (REVEAL-ND NPM1)

Singapore, April 2 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Revumenib in Combination with Int... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of GB-0895 Adjunctive Therapy in Adults and Adolescents with Severe Uncontrolled Asthma

Singapore, April 2 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of... Read More

Singapore Clinical Trial: A Phase 1 randomized, placebo-controlled multiple dose study to characterize the effects of LY4088182 on renal hemodynamics in participants with overweight or obesity.

Singapore, April 2 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, placebo-controlled multiple dose study to characterize the effects of LY4088... Read More

Singapore Clinical Trial: Platelet-Rich Plasma with Hyaluronic Acid Injections for Post- Viral Olfactory loss. A double-blinded RCT

Singapore, April 2 -- The Health Sciences Authority received information related to the study titled 'Platelet-Rich Plasma with Hyaluronic Acid Injections for Post- Viral Olfactory loss. A double-blin... Read More

Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, April 2 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemothera... Read More

• ««
• «
• 5374
• 5375
• 5376
• 5377
• 5378
• 5379
• 5380
• 5381
• 5382
• 5383
• »
• »»